BCRX
#1845
BioCryst Pharmaceuticals, Inc. - Common Stock
9.9 1 USD
-0.05%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-5.17%
Changement Mensuel
+13.13%
Evolution sur 6 mois
+46.60%
Changement Annuel
+10.11%
Clôture Précédente
10.4 5
Open
9.9 1
Low
9.9 1
High
9.9 1
Volume
258
Financials
- Market Capitalization 2.52 B
- Employee 435
- Founded 1986
- CEO Jon P. Stonehouse
- Website www.biocryst.com
- Headquarter Delaware, United States
- FIGI BBG000BLYWX6
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
6.45
ratio cours/chiffre d'affaires
1.95
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1829 |  KOD Kodiak Sciences Inc - Common Stock | 41.10 USD | -0.51% | +9.34% | +17.80% | +675.47% | 2.57 B USD | ||
| 1836 |  TARS Tarsus Pharmaceuticals, Inc. - Common Stock | 59.31 USD | +2.01% | -13.26% | -4.46% | -10.22% | 2.55 B USD | ||
| 1865 |  VCEL Vericel Corporation - Common Stock | 47.49 USD | +1.04% | +0.87% | +25.40% | +30.65% | 2.43 B USD | ||
| 1872 |  AGIO Agios Pharmaceuticals, Inc. - Common Stock | 40.55 USD | -1.65% | +2.35% | +36.58% | -6.55% | 2.41 B USD |